Topoisomerase Inhibitor — Chemotherapy: What to Expect
When you are told you will have topoisomerase inhibitor chemotherapy, it is natural to want to understand what it does and what to expect. These drugs stop cancer cells from copying their DNA by blocking enzymes the cells depend on. There are two types — and which type you are having changes which side effects matter most.
Medically reviewed by Dr. Naresh Gundu, Medical Oncologist, MBBS (Chalmeda Anand Rao Institute of Medical Sciences, Karimnagar) · DNB Internal Medicine (Sir Gangaram Hospital, New Delhi) · DM Medical Oncology (AIIMS) · Last reviewed September 2026
- Two types, two different profiles — Type I and Type II inhibitors block different enzymes and cause different side effects.
- Diarrhoea is the signature risk with Type I — Irinotecan causes a distinctive early and late diarrhoea pattern your team will explain before your first cycle.
- Heart monitoring with some Type II drugs — Anthracyclines such as doxorubicin and epirubicin can affect heart function with cumulative doses.
- Secondary leukaemia is rare but monitored — Both types carry a small risk of treatment-related blood cancer, which is why follow-up blood tests continue for years after treatment ends.
on Panel
Survival Rate*
Treated
(800+ reviews)
Topoisomerase inhibitors stop cancer cells from copying their DNA by blocking enzymes that unwind the double helix. Type I drugs — most commonly irinotecan — are most associated with diarrhoea. Type II drugs — including etoposide and the anthracyclines — can affect heart function over time and carry a small risk of treatment-related leukaemia.
How do Type I and Type II topoisomerase inhibitors differ?
| Feature | Type I inhibitors | Type II inhibitors |
|---|---|---|
| What it blocks | Topoisomerase I — manages single-strand DNA cuts | Topoisomerase II — manages double-strand DNA cuts |
| Common examples | Irinotecan, topotecan | Etoposide, doxorubicin, epirubicin, daunorubicin |
| Hair loss | Common, often moderate | Common — more significant with anthracyclines |
| Nausea and vomiting | Common | Common |
| Bone marrow suppression | Moderate to significant | Significant |
| Diarrhoea | Prominent — two distinct patterns | Less prominent |
| Heart effects | Not a primary concern | Possible with cumulative anthracycline doses |
| Secondary leukaemia risk | Small but present | Small but present — longer recognised with this class |
| Cancer types where class is used | Colorectal, ovarian, small-cell lung, cervical | Blood cancers, breast, lung, lymphoma, sarcoma |
How do topoisomerase inhibitors actually work?
Every time a cancer cell divides, it has to copy its DNA. To do that, the DNA double helix must uncoil — and then be re-coiled and repaired after copying.
Two enzymes manage this process. Topoisomerase I cuts one strand of the helix to relieve tension. Topoisomerase II cuts both strands at once. Inhibitors trap these enzymes mid-process, leaving broken DNA strands the cell cannot repair.
Cancer cells divide much faster than most normal cells. That constant copying is what makes them more vulnerable to this class. Some normal tissues that also divide quickly — particularly gut lining and bone marrow — are also affected, which is why diarrhoea and low blood counts are among the most common side effects.
Where to find us
Our centres in and around Hyderabad
Addressed by landmark, because that is how this city navigates. Each centre also names the areas it serves, so you can place it without a map. Consultation and day-care Chemotherapy run at every one of them.
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Get a straight answer from a specialist
45 minutes, your reports reviewed, your questions answered in plain language.
What precautions should you take during treatment?
- Tell your oncologist about every medicine you take — including Ayurvedic, herbal, and vitamin supplements.
- Report diarrhoea starting within 24 hours of your infusion. This is the early pattern seen with irinotecan and is managed differently from an ordinary stomach upset.
- Report diarrhoea starting or continuing more than 24 hours after treatment. Do not manage this at home with over-the-counter remedies without asking your team first.
- Attend all blood count tests between cycles — your team needs these results to plan the timing of your next treatment.
- Tell your team about any past heart condition before starting an anthracycline.
- Note and report any new breathlessness or ankle swelling during anthracycline treatment.
- Ask your oncologist which follow-up tests you will need after treatment ends.
Why does irinotecan cause two types of diarrhoea?
Irinotecan is unusual in causing two distinct patterns of diarrhoea, and they need different management.
The early type happens within 24 hours of your infusion. It is caused by the drug acting on nerve signals in the gut — a cholinergic effect — and is usually managed with a medicine your team will prescribe or have available on the day.
The late type starts more than 24 hours after treatment. This is caused by the drug damaging the gut lining directly and can become severe quickly. ASCO and NCCN guidance treats late diarrhoea on irinotecan as needing same-day contact with your team — not home management with over-the-counter remedies without asking first.
Tell your team which pattern you are experiencing, and when it started. The timing changes what your team will recommend.
Did you know?
Topoisomerase II inhibitors — including etoposide and the anthracyclines — carry a recognised small risk of treatment-related acute myeloid leukaemia (t-AML) that can appear months to years after treatment ends.
This risk is why your blood tests continue in follow-up rather than stopping when chemotherapy does. It is also why your oncologist tracks cumulative lifetime doses of these drugs.
Source: NCCN Long-Term Follow-Up Guidelines; ASCO Guidelines on Prevention and Management of Chemotherapy-Related Toxicities
Explore 95 more Understanding Chemotherapy, Myths & Trials topics
Types & Classes of Chemotherapy
- Alkylating Agent Chemotherapy: What to Expect
- Anthracycline Chemotherapy: What to Expect
- Antimetabolite Chemotherapy: What to Expect
- Biosimilars in Cancer Treatment
- Can Your Chemotherapy Be Changed Partway Through?
- Generic vs Innovator Chemotherapy Drugs
- Growth Factor Injections After Chemotherapy
- Platinum-Based Chemotherapy: What to Expect
- Single-Agent vs Combination Chemotherapy
- Supportive Medicines Given With Chemotherapy
- Taxane Chemotherapy: What to Expect
- Topoisomerase Inhibitor Chemotherapy: What to Expect
- Types of Chemotherapy: The Main Classes Explained
- Vinca Alkaloid Chemotherapy: What to Expect
- What Is Dose-Dense Chemotherapy?
- What Is Metronomic Chemotherapy?
- What Is a Chemotherapy Regimen?
- Why Am I Given Steroids With Chemotherapy?
- Why the Class of Chemotherapy Decides Your Side Effects
Does Chemotherapy Work? Realistic Expectations
- Can Chemotherapy Be Avoided With a Genomic Test?
- Can Chemotherapy Cure Cancer?
- Can You Stop Chemotherapy Midway?
- Chemotherapy When You Are Already Very Unwell
- Chemotherapy or Surgery First: How Is It Decided?
- Do Worse Side Effects Mean It Is Working Better?
- Does Chemotherapy Actually Work?
- Does Everyone React the Same Way to Chemotherapy?
- Getting Palliative Care Alongside Chemotherapy
- How Will I Know It Is Working?
- Is Chemotherapy Worth the Side Effects?
- Is Palliative Chemotherapy Worth Having?
- Is There an Alternative to Chemotherapy?
- Reduced-Dose Chemotherapy: When Is It Offered?
- What Does Palliative Chemotherapy Mean?
- What If Chemotherapy Does Not Work?
HUB — Chemotherapy Myths and Alternative Treatment Claims
HUB — What Is Chemotherapy and Why Has It Been Advised?
Is This Chemotherapy? Hormone and Targeted Therapy
- Are EGFR Tablets Like Gefitinib Chemotherapy?
- Are Steroids Chemotherapy?
- Chemotherapy vs Hormone Therapy
- Chemotherapy vs Immunotherapy
- Chemotherapy vs Targeted Therapy
- Do You Lose Your Hair on Every Cancer Medicine?
- Is Capecitabine Chemotherapy? Yes, and Why It Matters
- Is Every Cancer Medicine Chemotherapy?
- Is Imatinib Chemotherapy?
- Is Letrozole or Anastrozole Chemotherapy?
- Is Tamoxifen Chemotherapy?
- Which Precautions Apply to Which Treatment?
Myths & Alternative Treatment Claims
- Can Ayurveda Treat Cancer Instead of Chemotherapy?
- Can You Use Traditional Medicine Alongside Chemotherapy?
- Cannabis Oil and Cancer Treatment Claims
- Chemotherapy Myths in Telugu Households
- Do Cow Urine, Wheatgrass and Home Remedies Treat Cancer?
- Does Chemotherapy Kill You? The Evidence
- Homeopathy and Cancer Treatment Claims
- How to Spot a Fake Cancer Cure
- Is Chemotherapy Worse Than the Cancer?
- Myth: Chemotherapy Destroys Your Immunity Forever
- Myth: Chemotherapy Is Contagious or Dangerous to Others
- Myth: Chemotherapy Is Just a Money-Making Business
- Myth: Chemotherapy Means the Cancer Is Terminal
- Myth: Chemotherapy Patients Must Be Isolated
- Myth: Chemotherapy Spreads Cancer or Causes New Cancers
- Myth: Everyone Loses All Their Hair
- Myth: Once You Start Chemotherapy You Cannot Stop
- Myth: You Cannot Eat Anything During Chemotherapy
- Naturopathy, Detox and Alkaline Diet Claims
- Talking to a Family Member Who Refuses Chemotherapy
- What Happens If You Refuse Chemotherapy?
- Why Do People Believe Chemotherapy Does Not Work?
Understanding Chemotherapy & Why It Is Advised
- Can Chemotherapy Be Refused or Delayed?
- Can I Get a Second Opinion Before Starting?
- Chemotherapy After Surgery: Why It Is Needed
- Chemotherapy Before Surgery: Why It Is Given First
- Chemotherapy Terminology: A Plain-English Glossary
- Chemotherapy for a Cancer That Has Come Back
- Chemotherapy in a Clinical Trial
- Chemotherapy vs Targeted Therapy vs Immunotherapy
- Consent for Chemotherapy: What You Are Signing
- Curative, Adjuvant, Neoadjuvant and Palliative: What Your Intent Means
- Does Chemotherapy Mean My Cancer Is Advanced?
- How Long Does a Course of Chemotherapy Last?
- How Many Cycles of Chemotherapy Will I Need?
- Is Chemotherapy Painful?
- Questions to Ask Before Starting Chemotherapy
- What Chemotherapy Cannot Do
- What Happens Inside Your Body During Chemotherapy?
- What Is Chemoradiation?
- What Is Chemotherapy and How Does It Work?
- What Is Maintenance Chemotherapy?
- Who Decides Your Chemotherapy Plan?
- Why Has Chemotherapy Been Advised for Me?
- Why Is Chemotherapy Given in Cycles?
- Your Chemotherapy Plan Sheet: How to Read It
Still not sure what applies to you?
Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.
Frequently asked questions
Will I lose my hair on a topoisomerase inhibitor?
Hair loss varies by drug. Anthracyclines such as doxorubicin tend to cause significant hair loss. Irinotecan causes less dramatic thinning in most people. Topotecan falls in between. Your oncologist can tell you what to expect with the specific drug you are having, because variation within this class is wide. Hair almost always regrows after treatment ends, though the timing varies from person to person.
Is the diarrhoea from irinotecan dangerous?
It can be, if it becomes severe and is not reported promptly. The early type — starting within 24 hours — is usually short-lived and managed on the treatment day. The late type — starting more than 24 hours after treatment — can escalate quickly to dehydration and become a medical emergency if not treated. ASCO and NCCN guidance treats late diarrhoea on irinotecan as needing same-day contact with your team, not a wait-and-see approach. Most people manage well when it is reported early and treated correctly.
What heart monitoring will I need on doxorubicin or epirubicin?
Your team will assess your heart function before starting — usually with an echocardiogram — and at intervals during treatment. Anthracyclines can reduce the heart's pumping efficiency with cumulative doses, and this effect is not always reversible. Total lifetime dose is tracked, which is why your oncologist needs to know about any anthracyclines you have had before, even years earlier. Most people complete treatment without significant heart effects, but the monitoring is not optional — it is what makes the treatment safe.
What is treatment-related leukaemia and how likely is it?
Treatment-related acute myeloid leukaemia (t-AML) is a rare second cancer that can develop months to years after chemotherapy with topoisomerase II inhibitors. It is a recognised long-term risk in NCCN and ASCO follow-up guidance. It is uncommon — this is why surveillance blood tests continue after treatment ends, so that any early change is caught. Being informed of the risk is not a reason to avoid a treatment that is indicated for you; it is the reason your follow-up is structured the way it is.
Can I take loperamide at home for diarrhoea during treatment?
For the late diarrhoea pattern seen with irinotecan, many oncology teams do provide specific guidance on using loperamide at home — but only after explaining exactly when and how to use it. Do not start taking it without being told to. For the early cholinergic pattern, loperamide is the wrong medicine and will not help. The first step is always to tell your team which pattern you have and when it started — that information decides what they will recommend.
Are there lasting effects after topoisomerase inhibitor treatment finishes?
For most people, the acute side effects — nausea, diarrhoea, low blood counts — resolve after treatment ends. The effects to monitor for afterwards are the rarer long-term ones: heart function if you had anthracyclines, and blood count changes that might signal secondary leukaemia. This is why follow-up appointments and blood tests continue rather than stopping when treatment does. Tell your follow-up team about any unexplained fatigue, easy bruising, or repeated infections, even months after finishing chemotherapy.
Chemotherapy Topics
Browse our complete chemotherapy guide — 1133 pages on side effects, medicines, cost, daily life and care in Hyderabad. Tap any topic to read more.